More than 9 out of 10 Alzheimer's cases could be driven by specific variations in a single gene and the protein it produces, ...

A new LUMC study has changed our understanding of how cells work. Researchers have discovered that the CFAP20 protein acts as ...

The first patient has been dosed in a Phase 2 clinical trial testing RAG-17 in people with ALS who carry mutations in the ...

Precision and timing of gene expression is essential for normal biological functions and, when disrupted, can lead to many ...

UCSF scientists engineered old fibroblast cells to turn their genes on and off in the same way as young fibroblasts. The old ...

The FDA granted fast track status to VectorY’s VTx-002, an antibody gene therapy targeting TDP-43 protein aggregates in ALS.

We know the genes, but not their functions—to resolve this long-standing bottleneck in microbial research, a joint research ...

In a groundbreaking study published in the in Proceedings of the National Academy of Sciences (PNAS), scientists at Pacific ...

Potentially more than 90% of Alzheimer's disease cases would not occur without the contribution of a single gene (APOE), ...

British scientists have made a potentially important discovery related to dementia and Alzheimer’s disease that could pave ...

The need to change regulations around gene-editing treatments was endorsed in November by the head of the US Food and Drug ...

Attention can feel like a fragile thing, especially when your brain struggles to sort signal from noise. Every second, your ...